Kristen Scholer, Hive editor Jon Kelly, and the VF Hive panel discuss the top five stories of the week in technology, politics in business. Nick Bilton reports on his story about Donald Trump's threats to devalue the social media platforms that gave him his rise.
Nick also weighs in on early Facebook executive Chamath Palihapitiya's assertion that social media is tearing society apart. Scholer, Kelly and Bilton discuss whether that's true, and whether Facebook and Twitter will reach an inflection point.
Hive panelist Bess Levin talks about the latest trouble in Trumpland, with commerce secretary Wilbur Ross being accused of insider trading. Abigail Tracy reports on her story about Nikki Haley's potential political ambitions in 2020.
T.A. Frank winds up the Hive 5 with his analysis of the recent Senate Special Election in Alabama. Frank and the panel discuss Roy Moore's defeat and unlikely victory for Democrat Doug Jones. They cover the potential for future Democratic victories in Alabama, as well as Charles Barkley's message to the state prior to the election.
Manhattan District Attorney Alvin Bragg filed a federal lawsuit against Rep. Jim Jordan on Tuesday, accusing the Republican of a “transparent campaign to intimidate and attack” him over his prosecution of former President Donald Trump.
Nashville’s governing council voted Monday to send Justin Jones straight back to the Legislature four days after he was expelled for his role in a protest on the state House floor.
The Justice Department is calling a Texas court ruling that would halt approval of the most commonly used method of abortion in the U.S. "extraordinary and unprecedented."
Nashville city councilors will likely appoint Justin Jones to his former seat on Monday while Memphis-area county commissioners will soon announce when they'll meet to fill the vacancy left by the expulsion of Justin Pearson, which Pearson himself is eligible to fill.
Health and Human Services Secretary Xavier Becerra said "Everything is on the table" when asked if he'd recommend that the FDA ignore Friday's ruling to reverse the agency's nearly 23-year-old approval of the medication abortion drug mifepristone.
